Federated Hermes’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11K Buy
7,485
+516
+7% +$770 ﹤0.01% 1840
2026
Q1
$10.7K Sell
6,969
-304,130
-98% -$400K ﹤0.01% 1837
2025
Q4
$386K Sell
311,099
-260,944
-46% -$365K ﹤0.01% 1382
2025
Q3
$1.16M Sell
572,043
-4,321
-0.7% -$7.91K ﹤0.01% 1105
2025
Q2
$1.04M Sell
576,364
-17,757
-3% -$34.2K ﹤0.01% 1138
2025
Q1
$1.27M Buy
594,121
+474,862
+398% +$1.62M ﹤0.01% 1053
2024
Q4
$463K Buy
+119,259
New +$950K ﹤0.01% 1334
2023
Q3
Sell
-91
Closed -$2K 2106
2023
Q2
$2K Sell
91
-65
-42% -$2.04K ﹤0.01% 1994
2023
Q1
$4.84K Buy
+156
New +$1.94K ﹤0.01% 1938

Other funds holding BMEA

Federated Hermes's BMEA Position: Q2 2026 in Review

Federated Hermes increased its Biomea Fusion (BMEA) stake by 7.4% in Q2 2026, buying an estimated $770 and bringing the position to 7,485 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #1840.

Federated Hermes first reported a position in BMEA in Q1 2023 and has held it in 9 quarters since. The position peaked at $1.27M in Q1 2025. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

  • Federated Hermes held 7,485 shares of Biomea Fusion worth $11K as of Q2 2026.
  • Federated Hermes bought 516 Biomea Fusion shares in Q2 2026, an estimated $770.
  • Biomea Fusion made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1840 holding.
  • Federated Hermes first reported a position in Biomea Fusion in Q1 2023 and has held it in 9 quarters since.
  • Federated Hermes's Biomea Fusion position peaked at $1.27M in Q1 2025.
  • 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.